B. Braun pricing H.E.L.P. LDL cholesterol reduction system competitively with Kaneka's Liposorber.
This article was originally published in The Gray Sheet
Executive Summary
B. BRAUN MEDICAL H.E.L.P. LDL CHOLESTEROL REDUCTION SYSTEM will be priced competitively with Kaneka's Liposorber LA-15, the company says. The heparin-induced extracorporeal lipoprotein precipitation system, approved by FDA on Sept. 19, is the second device to gain approval for the reduction of low-density lipoprotein cholesterol in patients not responding to diet and drug therapies.